Cognition Therapeutics: A Beacon of Hope in the Fight Against Alzheimer’s and Neurodegenerative Diseases
Cognition Therapeutics, a Pittsburgh-based biopharmaceutical company, is working to develop small molecule therapeutics to target toxic proteins and halt or reverse the progression of Alzheimer’s disease and other degenerative brain disorders.
2 minutes to read